Skip to main content

Table 2 PEDro Scale risk of bias ratings for the included studies

From: Examining the effectiveness of virtual, augmented, and mixed reality (VAMR) therapy for upper limb recovery and activities of daily living in stroke patients: a systematic review and meta-analysis

Studies

Eligibility criteria

1

2

3

4

5

6

7

8

9

10

PEDro score

Ahmad et al. 2019 [24]

Y

1

0

1

0

0

1

1

1

1

1

7

Aşkın et al. 2018 [25]

Y

1

0

1

0

0

1

1

0

1

1

6

Assis et al. 2016 [26]

Y

1

0

1

0

0

0

1

1

1

1

6

Bergmann et al. 2017 [27]

Y

1

0

1

0

0

1

1

0

1

1

6

Brunner et al. 2017 [28]

Y

1

1

1

0

0

1

1

0

1

1

7

Byl et al.2013 [29]

N

1

0

1

0

0

1

0

0

1

1

5

Calabrò et al. 2017 [30]

Y

1

1

1

0

1

1

1

1

1

1

9

Cameirão et al. 2011 [14]

Y

1

0

0

0

0

1

0

0

1

1

4

Chen et al. 2015 [31]

Y

1

0

1

0

0

0

1

0

1

1

5

Cho et al. 2012 [32]

Y

1

0

1

0

0

0

1

0

1

1

5

Choi et al. 2016 [33]

Y

1

1

1

0

0

1

1

1

1

1

8

Duff et al. 2013 [34]

Y

1

0

1

0

0

1

0

0

1

1

5

El-Kafy et al. 2021 [35]

Y

1

0

1

0

0

1

1

0

1

1

6

Faria et al. 2018 [36]

Y

1

1

1

0

0

1

1

0

1

1

7

Ho et al. 2019 [37]

Y

1

1

1

0

0

0

0

0

1

1

5

Hung et al. 2019 [38]

Y

1

1

1

0

0

1

1

1

1

1

8

Ikbali Afsar et al. 2018 [39]

Y

1

1

1

0

0

1

0

0

1

1

6

In et al. 2012 [40]

Y

1

0

1

0

0

0

0

0

1

1

4

Johnson et al. 2020 [41]

Y

1

1

1

0

0

1

1

1

1

1

8

Kalron et al. 2016 [42]

N

1

1

1

0

0

1

1

0

1

1

7

Kim et al. 2018 [43]

N

1

1

1

1

0

1

0

1

1

1

8

Kiper et al. 2011 [44]

Y

1

0

1

0

0

0

1

0

1

1

5

Kiper et al. 2014 [45]

Y

1

0

1

0

0

0

1

0

1

1

5

Kottink et al. 2014 [46]

Y

1

0

1

0

0

1

1

0

1

1

6

Lee et al. 2014 [47]

Y

1

0

1

0

0

1

0

0

1

1

5

Lee et al. 2016 [48]

Y

1

1

1

0

0

1

1

1

1

1

8

Lee et al. 2018 [49]

Y

1

0

1

0

0

1

1

0

1

1

6

Levin et al. 2012 [50]

Y

1

0

1

0

0

1

1

0

1

1

6

Lin et al. 2018 [51]

Y

1

0

1

0

0

1

1

1

1

1

7

Lin et al. 2020 [52]

Y

1

1

1

1

0

0

1

1

1

1

8

ÖGÜN et al. 2019 [53]

Y

1

1

1

0

0

0

1

0

1

1

6

Oh et al. 2019 [54]

Y

1

1

1

0

0

1

1

0

1

1

7

Park et al. 2016 [55]

Y

1

0

1

0

0

1

1

0

1

1

6

Park et al. 2019 [56]

Y

1

1

1

0

0

1

1

0

1

1

7

Pedreira da Fonseca, 2017 [57]

Y

1

1

1

0

0

1

0

1

1

1

7

Piron et al. 2010 [58]

Y

1

1

1

0

0

1

1

1

1

1

8

Prange et al. 2015 [59]

Y

1

1

1

0

0

1

1

0

1

1

7

Saposnik et al. 2010 [60]

Y

1

0

1

0

0

1

0

0

1

1

5

Saposnik et al. 2016 [61]

Y

1

0

1

0

0

1

1

1

1

1

7

Shin et al. 2013 [62]

Y

1

0

1

0

0

1

1

0

1

0

5

Shin et al. 2014 [63]

Y

1

0

1

0

0

1

1

0

1

0

5

Shin et al. 2015 [64]

Y

1

0

1

0

0

1

1

0

1

1

6

Shin et al. 2016 [65]

Y

1

1

1

0

0

1

0

1

1

1

7

Sin et al. 2013 [66]

Y

1

0

1

0

0

1

1

0

1

1

6

Subramanian et al. 2013 [67]

N

1

1

1

0

0

1

1

0

1

1

7

Thielbar et al. 2020 [68]

Y

1

0

1

0

0

1

1

0

1

1

6

Tramontano et al. 2018 [69]

Y

1

 

1

0

0

1

1

0

1

1

6

Turolla et al. 2013 [70]

Y

1

0

1

0

0

1

0

0

1

1

5

Viana et al. 2014 [71]

Y

1

1

1

1

1

1

1

0

1

1

9

Yin et al. 2014 [72]

Y

1

0

1

0

0

1

1

0

1

1

6

  1. **PEDro items: 1 Random allocation; 2 Concealed allocation; 3 Baseline Comparability; 4 Blind subjects; 5 Blind therapists; 6 Blind assessors; 7 Adequate follow-up; 8 Intention to treat analysis; 9 Between-group statistical comparisons; 10 Point estimates and variability